Tumor Survivin Is Downregulated by the Antisense...

Clinical Cancer Research 2010 / 12 Vol. 16; Iss. 24

Tumor Survivin Is Downregulated by the Antisense Oligonucleotide LY2181308: A Proof-of-Concept, First-in-Human Dose Study

Talbot, D. C., Ranson, M., Davies, J., Lahn, M., Callies, S., Andre, V., Kadam, S., Burgess, M., Slapak, C., Olsen, A. L., McHugh, P. J., de Bono, J. S., Matthews, J., Saleem, A., Price, P.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
16
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-10-1932
Date:
December, 2010
File:
PDF, 1000 KB
english, 2010
Conversion to is in progress
Conversion to is failed